79 related articles for article (PubMed ID: 8249299)
1. NF kappa B upstream regulatory sequences of the HIV-1 LTR are involved in the inhibition of HIV-1 promoter activity by the NS proteins of autonomous parvoviruses H-1 and MVMp.
Faisst SR; Faisst S; Grangette C; Schlehofer JR; Rommelaere J
Virology; 1993 Dec; 197(2):770-3. PubMed ID: 8249299
[TBL] [Abstract][Full Text] [Related]
2. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
Kameoka M; Tanaka Y; Ota K; Itaya A; Yoshihara K
Biochem Biophys Res Commun; 1999 Aug; 262(1):285-9. PubMed ID: 10448106
[TBL] [Abstract][Full Text] [Related]
3. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of heterologous DNA replication by the MVMp nonstructural NS-1 protein: identification of a target sequence.
Tenenbaum L; Dupont F; Spegelaere P; Zentilin L; Norio P; Giacca M; Riva S; Falaschi A; Rommelaere J
Virology; 1993 Dec; 197(2):630-41. PubMed ID: 8249286
[TBL] [Abstract][Full Text] [Related]
7. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
8. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter.
Towers G; Harris J; Lang G; Collins MK; Latchman DS
AIDS; 1995 Feb; 9(2):129-36. PubMed ID: 7718183
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
11. A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits.
Safak M; Gallia GL; Khalili K
Virology; 1999 Sep; 262(1):178-89. PubMed ID: 10489351
[TBL] [Abstract][Full Text] [Related]
12. Mapping of upstream regulatory elements in the P4 promoter of parvovirus minute virus of mice.
Faisst S; Perros M; Deleu L; Spruyt N; Rommelaere J
Virology; 1994 Jul; 202(1):466-70. PubMed ID: 8009857
[TBL] [Abstract][Full Text] [Related]
13. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity.
Hiebenthal-Millow K; Pöhlmann S; Münch J; Kirchhoff F
Virology; 2004 Jul; 324(2):501-9. PubMed ID: 15207635
[TBL] [Abstract][Full Text] [Related]
15. The parvovirus H-1 NS2 protein affects viral gene expression through sequences in the 3' untranslated region.
Li X; Rhode SL
Virology; 1993 May; 194(1):10-9. PubMed ID: 8480414
[TBL] [Abstract][Full Text] [Related]
16. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.
Lusic M; Marcello A; Cereseto A; Giacca M
EMBO J; 2003 Dec; 22(24):6550-61. PubMed ID: 14657027
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
18. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
[TBL] [Abstract][Full Text] [Related]
19. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
